cedure, a double-isotope derivative procedure, and a competitive protein-binding assay procedure were used to determine 17-hydroxycorticosteroids in plasma from normal individuals and from patients with endocrinopathies.
Results from each of these procedures were intercompared. Results of the fluorometric procedure and the competitive proteinbinding assay compared favorably with results obtained by the more elaborate and difficult doubleisotope derivative method. The Porter and Silber method is less specific. This study should be a useful aid in comparing values with those of other laboratories and in selecting the most advantageous method for use by a particular laboratory.
AddItional Keyphrases:

Porter-Silber, fluorometric, double-isotope derivative, and competitive protein-binding procedures intercom pared
The lack of a method for determining plasma 17-OHCS2 that combines sensitivity, specificity, and technical simplicity has encouraged development of a variety of methods for measuring 17-OHCS concentrations in relatively crude plasma extracts. The most widely used methods are: the phenylhydrazinesulfuric acid-ethyl alcohol reagent of Porter and Silber (1) for colorimetric assay (2, 3) gives a high specificity and sensitivity for cortisol. The competitive protein-binding radioassay procedure described by Murphy et al. (6) was modified as follows: A 100-il aliquot of plasma was added to 1.0 ml of absolute ethanol in a 12 X 75 mm test tube. The contents were mixed, centrifuged, and the supernatant fluid was decanted to another 12 X 75 mm test tube. The percipitate was washed twice with ethanol, and the washings were pooled. The contents of the tubes containing the supernatant fluid and washings were dried and 1.0 ml of phosphate (14.2 g of Na2HPO4 + 20 ml of 1 molar HC1 per liter) buffer, pH 7.4, was added to the residue, followed by 0.5 ml of a solution (fivefold dilution) of human CBG plasma prepared in phosphate buffer and containing 4 tCi of tritiated cortisol (3H-F) per 100 ml of solution. The tubes were placed in a water bath at 40#{176}C for 5 mm, their contents thoroughly mixed on a vortex-type mixer, and the tubes transferred to a cold room at 4#{176}C for 15-30 mm. To remove unbound 17-OHCS, 80 mg of activated magnesium silicate (Florisil) was added to each tube, which was then vibrated for 1 mm on a vortex-type mixer. After allowing the contents to settle for at least 5 mm, or after centrifugation (1000 X g) for 5 mm at 4#{176}C, we removed a 0.5-ml aliquot and placed it into a scintillation counting vial. "Aquasol" (New England Nuclear Corp., Boston, Mass. 02118), 10 ml, was added, and each vial was counted for 10 mm. Standards containing 5-35 ng of cortisol per tube were run concurrently.
Materials and Methods
Heparinized
To facilitate the delivery of 80 mg of Florisil into each tube, we developed a dispenser that simultaneously delivered 80 mg (±0.5 mg) of Florisil into 40 tubes. This dispenser consisted of two metal plates, which contained 40 holes each. The top sliding plate was 3 mm thick and each hole was 1.0 cm in diameter. The bottom plate contained a small funnel-like exit port below each hole to facilitate delivery of Florisil into each tube. Cherian (12) has described a similar dispenser for adsorbents, which was constructed of "plexiglass."
Procedure 4
A double-isotope derivative procedure was used by New England Nuclear Biomedical Assay Laboratory to assay cortisol (F) and 11-deoxycortisol (5). Frozen samples were shipped to them and kept frozen until analyzed.
Results
A total of 69 plasma samples were analyzed by each of the four procedures. The results are intercompared in Table 2 and in Figures 1-8 .
The reproducibility of the fluorometric, Porter and Silber, and competitive protein-binding procedures was assessed by preparing aliquots of a pooled plasma and storing them frozen until analysis. Table 3 summarizes the results.
Discussion
Our data (Figures 1, 2, and 4) 11-deoxycortisol (13, 14) . Table 4 shows cedure for cortisol. The workof Pirke and Stamm (9) also supports this belief. The competitive protein-binding assay has advantages of speed, specificity, and freedom from nonsteroidal interference.
The excellent correlation noted in Figure 7 between results by competitive proteinbinding procedure and the double-isotope derivative procedure supports the contention that this method is specific. In addition, the comparison with New England Nuclear Laboratory results for compound F (Figure 8) show higher values for the competitive protein-binding, as expected because this method as outlined herein will measure both compounds F and S. Since the specificity of the routine methods for cortisol measurement by CPB depends on the selectivity of the solvent used to prepare the extract, the extraction procedure as outlined herein would not only deliver cortisol but also il-deoxycortisol, corticosterone, progesterone, and 17-hydroxyprogesterone.
However, the lower concentration of these steroids in normal plasma would not effect the values reported for cortisol, as demonstrated in work reported by Pirke and Stamm (10) . In certain clinical patients these steroids may become significant, and other procedures for preparing the steroid extracts should be used, such as pre-extraction with benzene (15) and carbon tetrachloride (16) before CPB measurement of cortisol with human CBG. In the reproducibility study carried out as shown in Table 3 , the standard deviation for the CPB assay procedure was shown to be greater than that obtained for the Porter and Silber or the fluorometric procedures.
The fluorometric and competitive protein-binding procedures gave comparable results in normal persons and patients deficient in 11-deoxycortisol. However, in samples containing significant concentrations of li-deoxycortisol, the fluorometric procedure gave lower values because this method will not measure li-deoxycortisol.
